Two virtual investor conferences next week! CEO Paul Truex & CBO Matt Killeen will present our progress:

→ Oppenheimer Private Life Sciences Company Showcase: Sept 29, 1:45 PM ET
→ Stifel Cardiometabolic Day: Sept 30, 10 AM ET

Meetings: [email protected]

#SGK1 #Biotech

Now live in JACC: Heart Failure: human genetic, preclinical and clinical evidence supporting SGK1 as a validated target and THRV-1268 as a potential first-in-class therapy for HFrEF.

Open-access paper: https://bit.ly/3T6ddMb
Full release: https://bit.ly/46oZrYo

#HFrEF #SGK1